- CEO
- Poramaporn Prasarttong-Osoth
- Full Time Employees
- 36,994
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 2, Soi Soonvijai 7 Bangkok Thailand 10310
- IPO Date
- Jan 8, 2009
- Business
- Bangkok Dusit Medical Services Public Company Limited Bangkok Dusit Medical Services Public Company Limited operates as Thailand's largest private healthcare provider, managing an extensive network of over 50 hospitals across the country and in Cambodia through six primary groups including Bangkok Hospital Group with multiple branches, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group; it delivers comprehensive medical services ranging from primary care and wellness programs at BDMS Wellness Clinic to advanced tertiary treatments in centers of excellence for orthopedics, trauma, cardiology, neuroscience, solid organ cancer, hematology cancer, and specialized areas such as robotic surgery, neurology, oncology, IVF, bone marrow transplants, CAR-T cell therapy, and medical tourism packages targeting international patients from Asia-Pacific and beyond. Founded in 1969 and headquartered at 2 Soi Soonvijai 7, New Phetchaburi Road in Bangkok, Thailand, the company serves diverse patient segments including Thai nationals under universal coverage, civil servants, social security recipients, and over two million annual international patients, with operations spanning central Thailand including Bangkok and its vicinity, northern, northeastern, eastern, and southern regions as well as Cambodia.
The company supports its hospital operations with subsidiaries providing ancillary services such as National Healthcare Systems for blood diagnostics, A.N.B. Laboratories and Medicpharma for laboratory testing and pharmaceutical production, and BDMS Medevac Center for emergency medical transportation and referrals. It emphasizes value-based care, adopting global clinical guidelines, advanced technologies like AI-driven diagnostics, electronic health records, genetic testing, and wearable devices for preventive health, while focusing on high-growth markets in tourist destinations like Chiang Mai, Pattaya, and Phuket.
Recent developments include the opening of Phyathai Sriracha 2 Hospital, a 113-bed secondary care facility in Chonburi's Eastern Economic Corridor, in March 2024 to address demand and reduce overcrowding at nearby tertiary sites; the launch of Phuket Cancer Center at Bangkok Siriroj Hospital, the first radiotherapy facility in Phuket and the Andaman region, in October 2024 with coordination from Wattanosoth Cancer Hospital; and the planned early 2025 opening of Samitivej International Children's Hospital with 103 beds in Bangkok's Srinakarin area. In May 2025, BDMS secured a pioneering 1,000 million baht green loan from TMBThanachart Bank, supported by the International Finance Corporation, to develop Bangkok International Hospital to LEED Healthcare Gold standards, marking Thailand's first such financing for a hospital. Additional expansions encompass a new rehabilitation building at Bangkok Hospital, bed additions at Bangkok Hospital Chiang Mai, and the forthcoming 220-bed Phyathai Bowin Hospital, alongside sustained partnerships such as with AstraZeneca in 2024 and an extended media alliance with CNN International for health programming.